Methyl 4-chloro-7-methoxyquinoline-6-carboxylate (CAS No: 205448-66-4) is a key pharmaceutical intermediate used in the synthesis of APIs Lenvatinib and . This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: 4-Chloro-7-methoxyquinoline-6-carboxylic acid methyl ester, Lenvatinib Impurity 18
CAS No: 205448-66-4
PubChem CID: 22646520
Mol Formula: C12H10ClNO3
Mol Weight: 251.66 g/mol
Used in APIs: Lenvatinib and
IUPAC Name: methyl 4-chloro-7-methoxyquinoline-6-carboxylate
API Intermediate Description: Methyl 4-chloro-7-methoxyquinoline-6-carboxylate is a key pharmaceutical intermediate used to build complex drug molecules, especially anti-cancer drugs (like Lenvatinib, a tyrosine kinase inhibitor) and potential antimalarials, by acting as a building block for inhibiting tumor growth pathways (like VEGF) or targeting malaria parasites. It's a versatile building block in organic synthesis for creating quinoline-based compounds with diverse biological activities.
